Instrumento Inactivo

Otros idiomas Proteostasis Therapeutics, Inc.

Acciones

PTI

US74373B1098

Otros idiomas

Desbloquee todas las noticias sobre todas las empresas: ¡No vuelvas a perderse una oportunidad de inversión rentable!

Proteostasis Therapeutics, Inc.(NasdaqGM:PTI) dropped from NASDAQ Composite Index	23/12/20
Proteostasis Therapeutics, Inc. : Stockholders Approve Business Combination with Yumanity Therapeutics, Inc.; Board Sets Reverse Stock Split Ratio	22/12/20
Yumanity Therapeutics Inc. completed the acquisition of Proteostasis Therapeutics, Inc. in a reverse merger transaction.	22/12/20
PROTEOSTASIS THERAPEUTICS, INC. : Other Events (form 8-K)	16/12/20
PROTEOSTASIS THERAPEUTICS, INC. : Entry into a Material Definitive Agreement, Unregistered Sale of Equity Securities, Other Events, Financial Statements and Exhibits (form 8-K)	15/12/20
PROTEOSTASIS THERAPEUTICS, INC. : Other Events (form 8-K)	09/12/20
PROTEOSTASIS THERAPEUTICS, INC. : Other Events, Financial Statements and Exhibits (form 8-K)	04/12/20
Proteostasis: 3Q Earnings Snapshot	16/11/20
Proteostasis: 3Q Earnings Snapshot	16/11/20
Proteostasis Therapeutics, Inc. Reports Earnings Results for the Third Quarter Ended September 30, 2020	16/11/20
Proteostasis Therapeutics : Reports Third Quarter 2020 Financial Results	16/11/20
PROTEOSTASIS THERAPEUTICS : Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)	16/11/20
PROTEOSTASIS THERAPEUTICS, INC. : Entry into a Material Definitive Agreement, Financial Statements and Exhibits (form 8-K)	06/11/20
WeissLaw LLP : Reminds BYFC, OTEL and PTI Shareholders About Its Ongoing Investigations	22/09/20
PROTEOSTASIS THERAPEUTICS, INC. : Change in Directors or Principal Officers, Other Events (form 8-K)	17/09/20
PROTEOSTASIS THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Proteostasis Therapeutics, Inc. - PTI	27/08/20
WeissLaw LLP Investigates Proteostasis Therapeutics, Inc.	25/08/20
PROTEOSTASIS THERAPEUTICS, INC. : Entry into a Material Definitive Agreement, Costs Associated with Exit or Disposal Activities, Material Modification to Rights of Security Holders, Change in Directors or Principal Officers, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Other Events, Financial Statements and Exhibits (form 8-K)	24/08/20
Proteostasis Therapeutics, Inc. Announces Resignation of Sheila Wilson as Chief Operating Officer	24/08/20
Proteostasis Therapeutics : Biotech Startup Yumanity Sets Reverse Merger With Proteostasis	24/08/20

No hay resultados para esta búsqueda

Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Otros idiomas Proteostasis Therapeutics, Inc.

Acciones

PTI

US74373B1098

Otros idiomas

Filtros